A5071868544- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Central Venous Catheters and Hemodialysis
- Cardiac Imaging and Diagnostics
- COVID-19 Clinical Research Studies
- Coronary Interventions and Diagnostics
- Peripheral Artery Disease Management
- Acute Ischemic Stroke Management
- Acute Myocardial Infarction Research
- Cardiac tumors and thrombi
- COVID-19 and healthcare impacts
- Mechanical Circulatory Support Devices
- Diagnosis and Treatment of Venous Diseases
- Heart Failure Treatment and Management
- Cardiac Arrhythmias and Treatments
- Vascular Procedures and Complications
- Cardiac Structural Anomalies and Repair
- Cardiac Valve Diseases and Treatments
- Long-Term Effects of COVID-19
- Multimedia Communication and Technology
- Blood Coagulation and Thrombosis Mechanisms
- Digital Rights Management and Security
- Sarcoma Diagnosis and Treatment
- Cardiac Arrest and Resuscitation
- Cerebrovascular and Carotid Artery Diseases
Osaka City General Hospital
2023-2025
Osaka Prefectural Medical Center
2022-2025
Toyonaka Municipal Hospital
2025
Hyogo Prefectural Amagasaki General Medical Center
2018-2024
OSG (Japan)
2023
Hyogo Prefectural Nishinomiya Hospital
2023
Shiga University of Medical Science
2023
Hospital Universitari i Politècnic La Fe
2021
RELX Group (United States)
2020
Osaka Police Hospital
2013-2017
This paper presents a new hand motion assist robot for rehabilitation therapy. The is an exoskeleton with 18 DOFs and self-motion control, which allows the impaired of patient to be driven by his or her healthy on opposite side. To provide such potential that able recover its ability level functional hand, designed support flexion/extension abduction/adduction motions fingers thumb independently as well opposability thumb. Moreover, it combination wrist. design specifications experimental...
There is a paucity of data on the management and prognosis cancer-associated venous thromboembolism (VTE), leading to uncertainty about optimal strategies.Methods Results:The COMMAND VTE Registry multicenter registry enrolling 3,027 consecutive acute symptomatic patients in Japan between 2010 2014. We divided entire cohort into 3 groups: active cancer (n=695, 23%), history (n=243, 8%), no (n=2089, 69%). The rate anticoagulation discontinuation was higher with (43.5%, 27.0%, respectively, at...
BACKGROUND: The optimal duration of anticoagulation therapy for isolated distal deep vein thrombosis in patients with cancer is clinically relevant, but the evidence lacking. prolonged could have a potential benefit prevention thrombotic events; however, it also increase risk bleeding. METHODS: In multicenter, open-label, adjudicator-blinded, randomized clinical trial at 60 institutions Japan, we randomly assigned thrombosis, 1-to-1 ratio, to receive either 12-month or 3-month edoxaban...
There has been limited data on anticoagulation strategies and long-term recurrence in patients with venous thromboembolism (VTE) the era of direct oral anticoagulant (DOAC).The COMMAND VTE Registry-2 is a multicenter retrospective cohort study enrolling 5197 consecutive acute symptomatic between January 2015 August 2020 among 31 centers Japan. In this primary report, entire was divided into 5 groups; major transient risk factors (N = 475, 9.1%), minor 788, 15%), unprovoked 1913, 37%),...
Intravascular ultrasound (IVUS) was only rarely used in landmark trials comparing percutaneous coronary intervention (PCI) with artery bypass grafting (CABG) patients multivessel disease.The authors aimed to evaluate clinical outcomes after optimal IVUS-guided PCI undergoing PCI.The OPTIVUS (OPTimal IntraVascular UltraSound)-Complex study cohort a prospective multicenter single-arm enrolling 1,021 PCI, including left anterior descending using IVUS, aiming meet the prespecified criteria...
BackgroundData on thrombosis and current real-world management strategies for anticoagulation therapy are scarce but important understanding issues unmet needs of an optimal patients with coronavirus disease 2019 (COVID-19).MethodThe CLOT-COVID Study (thrombosis antiCoaguLatiOn Therapy in COVID-19 Japan Study: UMIN000045800) was a retrospective, multicenter cohort study enrolling consecutive hospitalized among 16 centers from April 2021 to September 2021, we tried capture the status fourth...
Background It is unclear whether an intra‐aortic balloon pump (IABP) or percutaneous ventricular assist device (Impella) in combination with extracorporeal membrane oxygenation (ECMO) better. Methods Using the Japanese Diagnosis Procedure Combination database from September 2016 to March 2022, we identified inpatients who received Impella IABP ECMO (ECPella ECMO+IABP group, respectively). The primary outcome was in‐hospital mortality, and secondary outcomes included length of hospital stay,...
An intramyocardial dissecting hematoma (IMH) is a rare but potentially fatal complication of an acute myocardial infarction (AMI), typically resulting from hemorrhagic dissection within the spiral fibers. We present case 80-year-old man who experienced chest symptoms persisting for more than 24 hours. Despite immediate revascularization, patient unexpectedly developed cardiogenic shock during hospitalization and subsequently died. A pathological autopsy revealed relatively newly formed in...
Background: There is a paucity of data on the effect optimal intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) compared with standard PCI or artery bypass grafting (CABG) in patients multivessel disease.
Background Real-world data on clinical characteristics and outcomes related to the use of different direct oral anticoagulants (DOACs) for cancer-associated venous thromboembolism (VTE) is lacking. Methods The COMMAND VTE Registry-2 a multicenter registry enrolling 5,197 consecutive patients with acute symptomatic from 31 centers in Japan January 2015 August 2020. Our study population comprised 1,197 active cancer who were divided into edoxaban (N = 643, 54%), rivaroxaban 297, 25%), apixaban...
Coronavirus disease 2019 (COVID-19) reportedly causes venous thromboembolism (VTE), but the status of this complication in Japan was unclear.
Background The impact of major changes in the treatment practice pulmonary embolism (PE), such as limited indications for systemic thrombolysis and introduction direct oral anticoagulants, is not well documented. This study aimed to describe annual trends patterns outcomes patients with PE. Methods Results Using Japanese Diagnosis Procedure Combination inpatient database from April 2010 March 2021, we identified hospitalized Patients high-risk PE were defined those admitted out-of-hospital...
The coronavirus disease 2019 (COVID-19) causes extensive coagulopathy and a potential benefit of anticoagulation therapy has been documented for prevention thromboembolic events. Bleeding events also reported as notable complication; whereas, the incidence, risks, clinical impact bleeding remain unclear.The CLOT-COVID Study was nationwide, retrospective, multicenter cohort study on consecutive hospitalized patients with COVID-19 in Japan between April 2021 September 2021. In this...